Vancouver Sun -- Researchers are closing in on highly sensitive devices that trap bits of cancer circulating in the blood, offering a “liquid biopsy” that would give doctors and drug companies a better way to see if cancer drugs are working.
Vancouver Sun -- Researchers are closing in on highly sensitive devices that trap bits of cancer circulating in the blood, offering a “liquid biopsy” that would give doctors and drug companies a better way to see if cancer drugs are working.
